A Study of HS-20094 in Patients With T2DM
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 275 participants.
Also called NCT06901648
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 275 participants
- Registry
-
NCT06901648
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06901648. Randomized; double masking; primary purpose treatment. Start 2024-02-06 (actual); primary completion 2025-03-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of HS-20094 in Patients With T2DM
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- HS-20094
- Intervention (Drug)
- Dulaglutide
- Intervention (Drug)
- Palcebo
- Lead sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct06901648- Content hash
313eb333aecb0c03dfa72eab6e313565932413096b02b2939022b67e818d578b